Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gilaberte

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic settingF Arias, J J Padín, I Gilaberte, et al.
Journal of Investigational Allergology & Clinical Immunology|May 10, 2024
Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical TrialB Majorek-Olechowska, T Slomskis, L Zollerová, et al.
Journal of Affective Disorders|June 5, 1999
SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic studyT R Hylan, L Meneades, W H Crown, et al.
Actas Espanolas De Psiquiatria|September 22, 2007
Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM StudyA Montoya, J Pérez Sánchez Toledo, I Gilaberte, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Atencion Primaria|March 18, 1999
[The costs of treatment with the new antidepressants in clinical practice]J A Sacristán, I Gilaberte, T R Hylan, et al.
Journal of Affective Disorders|October 2, 2001
Use of olanzapine in dysphoric maniaA Gonzalez-Pinto, B Lalaguna, F Mosquera, et al.
International Clinical Psychopharmacology|April 12, 2000
Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trialJ A Sacristán, I Gilaberte, B Boto, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
Fluoxetine in the prevention of depressive recurrences: a double-blind studyI Gilaberte, A L Montejo, J de la Gandara, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic settingF Arias, J J Padín, I Gilaberte, et al.
Journal of Investigational Allergology & Clinical Immunology|May 10, 2024
Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical TrialB Majorek-Olechowska, T Slomskis, L Zollerová, et al.
Journal of Affective Disorders|June 5, 1999
SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic studyT R Hylan, L Meneades, W H Crown, et al.
Actas Espanolas De Psiquiatria|September 22, 2007
Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM StudyA Montoya, J Pérez Sánchez Toledo, I Gilaberte, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Atencion Primaria|March 18, 1999
[The costs of treatment with the new antidepressants in clinical practice]J A Sacristán, I Gilaberte, T R Hylan, et al.
Journal of Affective Disorders|October 2, 2001
Use of olanzapine in dysphoric maniaA Gonzalez-Pinto, B Lalaguna, F Mosquera, et al.
International Clinical Psychopharmacology|April 12, 2000
Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trialJ A Sacristán, I Gilaberte, B Boto, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
Fluoxetine in the prevention of depressive recurrences: a double-blind studyI Gilaberte, A L Montejo, J de la Gandara, et al.
Pageof 3